Back to Search
Start Over
Ligand Announces Completion of OmniAb Spin-Off
- Source :
- Plus Company Updates. November 2, 2022
- Publication Year :
- 2022
-
Abstract
- SAN DIEGO: Ligand Pharmaceuticals Incorporated has issued the following news release: Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced the company has completed the expected tax-free spin-off of its OmniAb antibody discovery [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.724873042